BNP Fast Test Kit
(Immunofluorescence Assay)
Intended Use
BNP Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of B-type natriuretic peptide (BNP) in human plasma and whole blood samples. This test is used as an aid in the diagnosis of congestive heart failure and for the risk stratification of patients with acute coronary syndromes (ACS).
About BNP
B-type natriuretic peptide (BNP) is a member of a class of hormones that regulate blood pressure. The heart is the main source of circulating BNP in humans. The molecule is released into the blood in response to increased heart pressure. Various studies have demonstrated that increased levels of circulating BNP are found in early stages of congestive heart failure (CHF, which occurs when the heart cannot deliver a sufficient amount of blood to the body). The level of BNP in the blood continues to increase as the CHF disease advances.
Specifications
|
Test Item |
Sample |
Detection Range |
Storage Condition |
|
BNP |
P/WB |
5.0~5000.0 pg/mL |
4-30℃ |
|
Method |
Test Time |
Cut-off Value |
Shelf Life |
|
Immunofluorescence Assay |
10 min |
100.0 pg/mL |
24 months |
Applicable Device
Getein 1100 Immunofluorescence Quantitative Analyzer
Getein 1160 Immunofluorescence Quantitative Analyzer
Getein 1180 Immunofluorescence Quantitative Analyzer
Getein 1200 Immunofluorescence Quantitative Analyzer
Getein 1600 Immunofluorescence Quantitative Analyzer
Clinical Application
1. Can be used for assessing the severity of CHF and risk stratification in patients with acute coronary syndromes.
2. As an aid in thediagnosis of the cause of dyspnea.
3. As an aid in thediagnosis or exclusion of HF.
4. As an aid in the monitoring and prognostic assessment of heart failure treatment.
5. As an aid in the diagnosis of the cause of cardiac insufficiency.
